Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharma Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN108997252B details a water-based green synthesis for oxadiazole derivatives, offering safer production and cost reduction in pharmaceutical intermediates manufacturing.
Patent CN1075055C details a novel one-pot reduction of amino acids to amino alcohols using unactivated borohydrides, offering significant cost reduction and high chiral purity for pharmaceutical manufacturing.
Patent CN103194501B reveals enzymatic synthesis for high purity chiral amino acids. Offers cost reduction and scalable supply for pharmaceutical intermediates manufacturing.
Patent CN115232164B reveals a visible-light catalyzed method for sulfonyl thiophosphates. This process offers mild conditions and high atom economy for reliable agrochemical intermediate supplier.
Discover a novel preparation method for rosuvastatin calcium intermediates featuring mild conditions, high yield, and superior stereocontrol for reliable pharmaceutical manufacturing.
Patent CN120309607A details high-purity Venetoclax intermediate synthesis. Offers cost reduction and supply reliability for API manufacturing.
Patent CN112047933B discloses a novel quinazolinone USP7 inhibitor synthesis with high yield and mild conditions, offering cost-effective solutions for pharmaceutical intermediates.
Patent CN112939911A reveals a novel chiral resolution process for L-Corey lactone intermediates, offering high optical purity and scalable manufacturing for prostaglandin synthesis.
Advanced synthesis of Pemetrexed disodium intermediate via amino protection strategy. Reduces impurities, lowers costs, and ensures reliable supply for oncology drug manufacturing.
Patent CN103360410A reveals a novel Ofloxacin preparation method using trimethylchlorosilane for dual protection, significantly improving yield and reducing impurities for pharmaceutical manufacturing.
Patent CN116178428A reveals a safe, high-yield synthesis for P,O-hybrid ligands, eliminating hazardous Grignard reagents for reliable pharmaceutical intermediate supply.
Patent CN112939925A reveals a mild synthetic route for long-chain alkanoic acid derivatives, offering cost reduction and scalability for API manufacturing.
Patent CN119876067B reveals high-activity carbonyl reductase mutants for diltiazem intermediates, offering scalable biocatalytic solutions for pharmaceutical manufacturing.
Patent CN103483363A reveals a novel Cu-NHC catalyzed route for diverse chiral aminoboronic acids, offering high stereoselectivity and simplified manufacturing for API intermediates.
Advanced preparation method for high-purity deuterated aromatics using polyfluoric anhydride. Cost-effective solution for OLED materials and pharmaceutical intermediates.
Patent CN113321638A details a robust synthesis for stable fluorescent dyes. Enables 8+ color test kits with high quantum yield and scalable manufacturing processes.
Novel copper-catalyzed synthesis patent CN120923413A offers high-purity pharmaceutical intermediates with reduced metal residue risks and scalable production capabilities.
Novel synthesis of phenolic hydroxyl-functionalized BODIPY dyes via room-temperature chloranil oxidation. Enables scalable production of high-purity bio-markers with superior photostability.
Novel patent CN120795013A reveals high-purity isoxazole synthesis route enabling cost reduction in API manufacturing and reliable pharmaceutical intermediates supplier capabilities.
Advanced preparation of racemic hydroxy methionine calcium via controlled diazotization. High purity >97% for pharmaceutical and feed applications with optimized cost efficiency.